Use of Infrared Photomodulation for Hormonal Balance (Joovvin' for Hormonal Health)

Testosterone Deficiency Clinical Trial

Official title:

Joovvin' for Hormonal Health

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT04245527
• Other study ID #: 2216
• Status: Not yet recruiting
• Phase: N/A
• Start date: January 31, 2020
• Est. completion date: June 1, 2020

Study information

• Verified date: January 2020
• Source: ProofPilot
• Contact: Matthew M Amsden
• Phone: 3232844626
• Email: crew[@]proofpilot.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

8-week pilot study looking at the impact of Joovv's infrared photo modulation product on male and female hormone levels.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 60
• Est. completion date: June 1, 2020
• Est. primary completion date: May 1, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• United States resident

Exclusion Criteria:

• current Joovv or other photomodulation therapy user

• under medical supervision for medically treatable illness

• significant travel during study period

• use of birth control

Related Conditions & MeSH terms

• Estrogen Deficiency
• Testosterone Deficiency

Intervention

Device:
• Joovv Infrared Light Device
Joovv is the leading manufacturer of personal, in-home red light therapy devices

Locations

Country	Name	City	State
United States	ProofPilot (Virtual Study: https://p.proofpilot.com)	New York	New York

Sponsors (2)

Lead Sponsor	Collaborator
ProofPilot	Joovv

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Testosterone Change	in males, change from baseline to week 8	baseline to week 8
Primary	change of thyroid-stimulating hormone (TSH)	in females change in estrogen and progesterone from baseline to week 8	baseline to week 8
Primary	Self report general wellness	series of questions at baseline and week 8 on general wellness (modified Short Form-36)	baseline to week 8